# PNC Financial Services Group, Inc.: financial statements, quarterly

PNC · NYSE · CIK 713676 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pnc.md) · [Financials](/companies/pnc/financials.md) · [Filings](/companies/pnc/filings.md) · [Insiders](/companies/pnc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pnc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,233](/filings/0000713676-23-000079.md) | [5,361 d](/filings/0000713676-26-000020.md) | [5,145](/filings/0000713676-24-000046.md) | [5,411](/filings/0000713676-25-000060.md) | [5,432](/filings/0000713676-25-000132.md) | [5,567 d](/filings/0000713676-26-000020.md) | [5,452](/filings/0000713676-26-000038.md) | [5,661](/filings/0001628280-26-053170.md) | [5,915](/filings/0000713676-25-000132.md) | [6,071 d](/filings/0000713676-26-000020.md) | [6,165](/filings/0000713676-26-000038.md) | [6,875](/filings/0001628280-26-053170.md) |
| Interest expense | $m | [2,785](/filings/0000713676-23-000079.md) | [3,099 d](/filings/0000713676-24-000028.md) | [3,236](/filings/0000713676-24-000046.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [289](/filings/0000713676-24-000081.md) | [172 d](/filings/0000713676-26-000020.md) | [312](/filings/0001628280-25-021752.md) | [342](/filings/0000713676-25-000060.md) | [357](/filings/0000713676-25-000132.md) | [278 d](/filings/0000713676-26-000020.md) | [347](/filings/0000713676-26-000038.md) | [381](/filings/0001628280-26-053170.md) | [465](/filings/0000713676-25-000132.md) | [296 d](/filings/0000713676-26-000020.md) | [415](/filings/0000713676-26-000038.md) | [531](/filings/0001628280-26-053170.md) |
| Net income | $m | [1,570](/filings/0000713676-24-000081.md) | [883 d](/filings/0000713676-26-000020.md) | [1,344](/filings/0001628280-25-021752.md) | [1,477](/filings/0000713676-25-000060.md) | [1,505](/filings/0000713676-25-000132.md) | [1,627 d](/filings/0000713676-26-000020.md) | [1,499](/filings/0000713676-26-000038.md) | [1,627](/filings/0001628280-26-053170.md) | [1,822](/filings/0000713676-25-000132.md) | [2,033 d](/filings/0000713676-26-000020.md) | [1,772](/filings/0000713676-26-000038.md) | [2,040](/filings/0001628280-26-053170.md) |
| Diluted EPS | $ per share | [3.60](/filings/0000713676-24-000081.md) | not reported | [3.10](/filings/0001628280-25-021752.md) | [3.39](/filings/0000713676-25-000060.md) | [3.49](/filings/0000713676-25-000132.md) | not reported | [3.51](/filings/0000713676-26-000038.md) | [3.85](/filings/0001628280-26-053170.md) | [4.35](/filings/0000713676-25-000132.md) | not reported | [4.13](/filings/0000713676-26-000038.md) | [4.81](/filings/0001628280-26-053170.md) |
| Basic EPS | $ per share | [3.60](/filings/0000713676-24-000081.md) | not reported | [3.10](/filings/0001628280-25-021752.md) | [3.39](/filings/0000713676-25-000060.md) | [3.50](/filings/0000713676-25-000132.md) | not reported | [3.52](/filings/0000713676-26-000038.md) | [3.86](/filings/0001628280-26-053170.md) | [4.36](/filings/0000713676-25-000132.md) | not reported | [4.13](/filings/0000713676-26-000038.md) | [4.82](/filings/0001628280-26-053170.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [46.3](/filings/0000713676-24-000081.md) | [49.7](/filings/0000713676-25-000027.md) | [58.6](/filings/0001628280-25-021752.md) | [38.4](/filings/0000713676-25-000060.md) | [40.3](/filings/0000713676-24-000081.md) | [45.3](/filings/0000713676-25-000027.md) | [37.4](/filings/0001628280-25-021752.md) | [29.4](/filings/0000713676-25-000060.md) | not reported | not reported | not reported | not reported |
| Total assets | $bn | [557](/filings/0000713676-23-000079.md) | [562](/filings/0000713676-25-000027.md) | [566](/filings/0000713676-24-000046.md) | [557](/filings/0000713676-24-000068.md) | [565](/filings/0000713676-24-000081.md) | [560](/filings/0000713676-26-000020.md) | [555](/filings/0001628280-25-021752.md) | [559](/filings/0000713676-25-000060.md) | [569](/filings/0000713676-25-000132.md) | [574](/filings/0001628280-26-053170.md) | [603](/filings/0000713676-26-000038.md) | [616](/filings/0001628280-26-053170.md) |
| Total liabilities | $bn | [508](/filings/0000713676-23-000079.md) | [510](/filings/0000713676-25-000027.md) | [515](/filings/0000713676-24-000046.md) | [504](/filings/0000713676-24-000068.md) | [509](/filings/0000713676-24-000081.md) | [506](/filings/0000713676-26-000020.md) | [498](/filings/0001628280-25-021752.md) | [501](/filings/0000713676-25-000060.md) | [510](/filings/0000713676-25-000132.md) | [513](/filings/0001628280-26-053170.md) | [539](/filings/0000713676-26-000038.md) | [552](/filings/0001628280-26-053170.md) |
| Long-term debt | $bn | [66.2](/filings/0000713676-23-000079.md) | [72.7](/filings/0000713676-25-000027.md) | [72.7](/filings/0000713676-24-000046.md) | [71.4](/filings/0000713676-24-000068.md) | [68.1](/filings/0000713676-24-000081.md) | [61.7](/filings/0000713676-26-000020.md) | [60.7](/filings/0001628280-25-021752.md) | [60.4](/filings/0000713676-25-000060.md) | [62.3](/filings/0000713676-25-000132.md) | [57.1](/filings/0001628280-26-053170.md) | [66.7](/filings/0000713676-26-000038.md) | [85.7](/filings/0001628280-26-053170.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [49.5](/filings/0000713676-23-000079.md) | [51.1](/filings/0000713676-25-000027.md) | [51.3](/filings/0000713676-24-000046.md) | [52.6](/filings/0000713676-24-000068.md) | [55.7](/filings/0000713676-24-000081.md) | [54.4](/filings/0000713676-26-000020.md) | [56.4](/filings/0001628280-25-021752.md) | [57.6](/filings/0000713676-25-000060.md) | [59.0](/filings/0000713676-25-000132.md) | [60.6](/filings/0001628280-26-053170.md) | [63.6](/filings/0000713676-26-000038.md) | [64.0](/filings/0001628280-26-053170.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [115 d](/filings/0000713676-24-000081.md) | [4,864 d](/filings/0000713676-26-000020.md) | [1,758](/filings/0001628280-25-021752.md) | [1,035 d](/filings/0000713676-25-000060.md) | [3,287 d](/filings/0000713676-25-000132.md) | [1,800 d](/filings/0000713676-26-000020.md) | [(509)](/filings/0000713676-26-000038.md) | [1,480 d](/filings/0001628280-26-053170.md) | [2,656 d](/filings/0000713676-25-000132.md) | [757 d](/filings/0000713676-26-000020.md) | [1,928](/filings/0000713676-26-000038.md) | [2,147 d](/filings/0001628280-26-053170.md) |
| Dividends paid | $m | [624 d](/filings/0000713676-24-000081.md) | [624 d](/filings/0000713676-26-000020.md) | [624](/filings/0001628280-25-021752.md) | [623 d](/filings/0000713676-25-000060.md) | [646 d](/filings/0000713676-25-000132.md) | [644 d](/filings/0000713676-26-000020.md) | [639](/filings/0000713676-26-000038.md) | [642 d](/filings/0001628280-26-053170.md) | [678 d](/filings/0000713676-25-000132.md) | [676 d](/filings/0000713676-26-000020.md) | [696](/filings/0000713676-26-000038.md) | [691 d](/filings/0001628280-26-053170.md) |
| Share repurchases | $m | [11.0 d](/filings/0000713676-24-000081.md) | [52.0 d](/filings/0000713676-26-000020.md) | [223](/filings/0001628280-25-021752.md) | [113 d](/filings/0000713676-25-000060.md) | [130 d](/filings/0000713676-25-000132.md) | [221 d](/filings/0000713676-26-000020.md) | [262](/filings/0000713676-26-000038.md) | [336 d](/filings/0001628280-26-053170.md) | [334 d](/filings/0000713676-25-000132.md) | [406 d](/filings/0000713676-26-000020.md) | [796](/filings/0000713676-26-000038.md) | [622 d](/filings/0001628280-26-053170.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [410](/filings/0000713676-23-000079.md) | [402](/filings/0000713676-24-000046.md) | [401](/filings/0000713676-24-000068.md) | [400](/filings/0000713676-24-000081.md) | [400](/filings/0001628280-25-021752.md) | [400](/filings/0000713676-25-000060.md) | [400](/filings/0000713676-25-000132.md) | [398](/filings/0000713676-26-000038.md) | [397](/filings/0001628280-26-053170.md) | [396](/filings/0000713676-25-000132.md) | [405](/filings/0000713676-26-000038.md) | [403](/filings/0001628280-26-053170.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 398,943,667 at 2026-07-20, from the cover of the [10-Q filed 2026-08-05](/filings/0001628280-26-053170.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.